Björg Ásbjörnsdóttir
Novo Nordisk (Denmark)(DK)
Publications by Year
Research Areas
Gestational Diabetes Research and Management, Diabetes Management and Research, Pregnancy and preeclampsia studies, Birth, Development, and Health, Diabetes Treatment and Management
Most-Cited Works
- → Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial(2023)132 cited
- → Higher Gestational Weight Gain Is Associated With Increasing Offspring Birth Weight Independent of Maternal Glycemic Control in Women With Type 1 Diabetes(2014)79 cited
- → Impact of Restricted Maternal Weight Gain on Fetal Growth and Perinatal Morbidity in Obese Women With Type 2 Diabetes(2012)62 cited
- → Fetal growth in relation to gestational weight gain in women with Type 2 diabetes: an observational study(2014)52 cited
- → Diastolic blood pressure is a potentially modifiable risk factor for preeclampsia in women with pre-existing diabetes(2018)46 cited
- → Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes(2021)30 cited
- → Effect of motivational interviewing on gestational weight gain and fetal growth in pregnant women with type 2 diabetes(2019)28 cited
- → Prevalence and severity of diabetic retinopathy in pregnant women with diabetes—time to individualize photo screening frequency(2022)23 cited
- → Continuous Glucose Monitoring–Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4(2024)21 cited
- → Prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes and the impact on glycaemic control(2020)21 cited